Upgrade to SI Premium - Free Trial

GlucoTrack (GCTK)

0.64 -0.01 (1.54%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (9/25/26 *Est.)

Latest Headlines

Form 8-K Glucotrack, Inc. For: Oct 13 October 19, 2026 4:05 PM - SEC Filing Form PRE 14A Glucotrack, Inc. For: Oct 13 October 14, 2026 10:02 AM - SEC Filing Qare™ Is Here: Lōkahi Therapeutics™ Launches a Proprietary New Way to Compare Your Care, Beginning with GLP-1 Medications October 14, 2026 9:00 AM - BizWire Form S-1/A Glucotrack, Inc. October 14, 2026 6:03 AM - SEC Filing Form 425 Glucotrack, Inc. Filed by: Glucotrack, Inc. October 13, 2026 4:46 PM - SEC Filing Form 8-K/A Glucotrack, Inc. For: Jul 09 October 13, 2026 4:45 PM - SEC Filing Lōkahi Therapeutics™ Expands University of Georgia Collaboration Through First International ai² Pipeline™ Project with Universität Paderborn October 1, 2026 5:15 PM - BizWire Glucotrack unit to launch GLP-1 patient comparison app in October September 30, 2026 9:01 AM - StreetInsider Lōkahi Therapeutics™ Announces Qare™, the First Real-Time Comparative Health Platform for GLP-1 Medications, with Public Availability Beginning October 14 September 30, 2026 9:00 AM - BizWire Form 8-K Glucotrack, Inc. For: Sep 22 September 28, 2026 5:29 PM - SEC Filing Form 424B5 Glucotrack, Inc. September 28, 2026 11:50 AM - SEC Filing Lōkahi Therapeutics partners with Pepperdine on pipeline program September 25, 2026 9:00 AM - StreetInsider Lōkahi Therapeutics™ Expands ai² Pipeline™ Program Through Collaboration with Pepperdine E2B™ September 25, 2026 9:00 AM - BizWire Form 424B5 Glucotrack, Inc. September 24, 2026 5:25 PM - SEC Filing Form 8-K Glucotrack, Inc. For: Sep 24 September 24, 2026 5:15 PM - SEC Filing Glucotrack prices $3.1M public offering at $2.04 per share September 24, 2026 8:45 AM - StreetInsider Glucotrack, Inc. Announces Pricing of $3 Million Public Offering September 24, 2026 8:45 AM - BizWire Lōkahi Therapeutics signs first external client for asset search platform September 23, 2026 4:30 PM - StreetInsider Lōkahi Therapeutics™ Advances its Proprietary ai² PIPELINE (formerly ai² Futures Lab) Process from Internal Asset Engine to Revenue-Generating Platform September 23, 2026 4:30 PM - BizWire Form 425 Glucotrack, Inc. Filed by: Glucotrack, Inc. September 23, 2026 9:22 AM - SEC Filing Form 8-K Glucotrack, Inc. For: Sep 23 September 23, 2026 9:22 AM - SEC Filing Glucotrack unit submits LT-100 clinical protocol for osteoarthritis September 23, 2026 9:01 AM - StreetInsider Lōkahi Therapeutics™ and Glucotrack CEO Erik Emerson Provides Strategic Update on LT-100, ai² Platform Growth and Clinical Development Priorities September 23, 2026 9:00 AM - BizWire Form 8-K Glucotrack, Inc. For: Sep 14 September 18, 2026 5:10 PM - SEC Filing Lōkahi Therapeutics™ Continues ai² Pipeline™ Division Collaboration with The University of Alabama to Advance Asset Evaluation and Biopharma Talent September 18, 2026 9:00 AM - BizWire GlucoTrack (GCTK) files for 43.45M share offering by selling stockholders September 18, 2026 6:06 AM - StreetInsider Form S-1 Glucotrack, Inc. September 18, 2026 6:02 AM - SEC Filing Form 8-K Glucotrack, Inc. For: Sep 11 September 14, 2026 4:15 PM - SEC Filing Form 8-K Glucotrack, Inc. For: Sep 10 September 11, 2026 5:20 PM - SEC Filing Glucotrack secures $11.5M in convertible note financing September 11, 2026 8:01 AM - StreetInsider Glucotrack Announces $11.5 Million Financing September 11, 2026 8:00 AM - BizWire Form 8-K Glucotrack, Inc. For: Aug 28 August 28, 2026 5:15 PM - SEC Filing Form 425 Glucotrack, Inc. Filed by: Glucotrack, Inc. August 28, 2026 4:33 PM - SEC Filing Form 8-K/A Glucotrack, Inc. For: Jul 09 August 28, 2026 4:29 PM - SEC Filing Form 8-K Glucotrack, Inc. For: Aug 27 August 27, 2026 8:45 AM - SEC Filing Glucotrack announces 1-for-15 reverse stock split effective Aug. 31 August 27, 2026 8:01 AM - StreetInsider Glucotrack, Inc. Announces Reverse Stock Split August 27, 2026 8:00 AM - BizWire Lōkahi Therapeutics™ Initiates Clinical Trial Manufacturing for LT-100 August 25, 2026 8:00 AM - BizWire Form DEFA14A Glucotrack, Inc. August 21, 2026 4:06 PM - SEC Filing Lokahi Therapeutics renews University of Georgia academic program tie August 21, 2026 8:00 AM - StreetInsider Lōkahi Therapeutics™ Expands ai² Futures Lab™ Asset Origination Network Through Continued Collaboration with the University of Georgia August 21, 2026 8:00 AM - BizWire Form 8-K Glucotrack, Inc. For: Aug 18 August 19, 2026 9:01 AM - SEC Filing Glucotrack regains Nasdaq compliance with stockholders' equity rule August 17, 2026 8:00 AM - StreetInsider Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation August 17, 2026 8:00 AM - BizWire Form 10-Q Glucotrack, Inc. For: Jun 30 August 14, 2026 4:12 PM - SEC Filing Form DEF 14A Glucotrack, Inc. For: Aug 10 August 10, 2026 5:33 PM - SEC Filing Form 8-K Glucotrack, Inc. For: Aug 07 August 10, 2026 4:06 PM - SEC Filing E.F. Hutton & Co. Acts as Exclusive Financial Advisor for $5.5 Million Financing for Glucotrack August 6, 2026 8:15 AM - Globe NewsWire E.F. Hutton & Co. Acts as Exclusive Financial Advisor for $5.5 Million Financing for Glucotrack August 6, 2026 8:15 AM - StreetInsider Form 8-K Glucotrack, Inc. For: Aug 04 August 5, 2026 5:21 PM - SEC Filing Glucotrack Announces $5.5 Million Financing August 5, 2026 8:30 AM - BizWire CORRECTING and REPLACING Lōkahi Therapeutics™ ai² Futures Lab™ Changes How Biopharma Builds a Pipeline August 3, 2026 8:49 AM - BizWire Form PRE 14A Glucotrack, Inc. For: Jul 31 July 31, 2026 5:07 PM - SEC Filing Lōkahi Therapeutics™ ai² Futures Lab™ Changes How Biopharma Builds a Pipeline July 31, 2026 8:00 AM - BizWire Form 8-K Glucotrack, Inc. For: Jul 29 July 30, 2026 5:29 PM - SEC Filing Lōkahi Therapeutics™ Advances LT-100 Development Strategy Toward Single-Injection Administration July 29, 2026 5:30 PM - BizWire Form 8-K/A Glucotrack, Inc. For: Jul 22 July 29, 2026 5:15 PM - SEC Filing Form 8-K Glucotrack, Inc. For: Jul 22 July 27, 2026 4:30 PM - SEC Filing Full Article List